New model for drug development needed in leukaemia.
Nierengarten
Mary Beth
MB
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D015195:Drug Design; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D015398:Signal Transduction / Q000502:physiology*
D000970:Antineoplastic Agents